Misplaced Pages

Exbivirumab is a human monoclonal antibody developed for the treatment of hepatitis B infections.

References

1. "WHO Drug Information" (PDF). Archived from the original (PDF) on 2011-05-11. Retrieved 2009-09-24.
2. Shouval D, Terrault N, Galun E, Samuel D, Gane E, Pruett T, et al. (2006). "Anti-Viral Effects, Pharmacokinetics and Safety of Two Human Monoclonal Anti-Hbs (Libivirumab/Exbivirumab) Versus Hepatitis B Immune Globulin (Hbig) in Hepatitis B Virus (Hbv) in Liver Transplant (Lt) Recipients". Hepatology. 44 (4): 188A–700A . doi:10.1002/hep.21395.

This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Drugs not assigned an ATC code
• Experimental monoclonal antibodies
• Antiinfective agent stubs
• Monoclonal antibody stubs